Related Experiment Video
Updated: Jun 24, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
[Peptide aptamers and nano-carriers for cancer therapy]
1Division of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research.
Abstract:
Peptide aptamers are specific binders that are artificially created using in vitro evolution systems. The peptide aptamers that can detect malignant cells in vivo, or can bind surfaces of various materials will enable us to develop novel types of cancer diagnosis and cancer therapy agents by combining with various nano-carriers. Here, the development of peptide aptamer research is described in terms of artificial protein research. Also, two examples of nano-carriers are introduced, i. e., a ferritin, a natural caged protein, and carbon nanohorns, members of the carbon nanomaterial family, by focusing their potential roles in cancer diagnosis and cancer therapy.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted

